KRISTIN ECKEL-MAHAN to Cell Line, Tumor
This is a "connection" page, showing publications KRISTIN ECKEL-MAHAN has written about Cell Line, Tumor.
Connection Strength
0.276
-
Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma. Cell Rep. 2025 Nov 25; 44(11):116313.
Score: 0.135
-
HNF4a-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. Cancer Res. 2019 11 15; 79(22):5860-5873.
Score: 0.089
-
ROR activation by Nobiletin enhances antitumor efficacy via suppression of I?B/NF-?B signaling in triple-negative breast cancer. Cell Death Dis. 2022 04 19; 13(4):374.
Score: 0.027
-
Restoration of the molecular clock is tumor suppressive in neuroblastoma. Nat Commun. 2021 06 28; 12(1):4006.
Score: 0.025